+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Akorn Operating Company LLC - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 29 Pages
  • March 2023
  • GlobalData
  • ID: 5713642
Akorn Operating Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Akorn Operating Company LLC (Akorn), formerly Akorn Inc, is a specialty pharmaceutical company. It develops, manufactures and commercializes branded and prescription drugs, over-the-counter (OTC), eye care, and consumer health, as well as animal health and eye care products. The company offers its products in both sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. The company caters to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations, and other pharmaceutical companies. Akorn is headquartered in Gurnee, Illinois, the US.

Akorn Operating Company LLC Key Recent Developments

  • Sep 15, 2022: Pharmaceutical company Akorn agrees to pay $7.9 million for allegedly causing Medicare to pay for invalid prescription drugs

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Akorn Operating Company LLC - Key Facts
  • Akorn Operating Company LLC - Key Employees
  • Akorn Operating Company LLC - Key Employee Biographies
  • Akorn Operating Company LLC - Major Products and Services
  • Akorn Operating Company LLC - History
  • Akorn Operating Company LLC - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Akorn Operating Company LLC - Business Description
  • Akorn Operating Company LLC - Corporate Strategy
  • Akorn Operating Company LLC - SWOT Analysis
  • SWOT Analysis - Overview
  • Akorn Operating Company LLC - Strengths
  • Akorn Operating Company LLC - Weaknesses
  • Akorn Operating Company LLC - Opportunities
  • Akorn Operating Company LLC - Threats
  • Akorn Operating Company LLC - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Akorn Operating Company LLC, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Akorn Operating Company LLC, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Akorn Operating Company LLC, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Sep 15, 2022: Pharmaceutical company Akorn agrees to pay $7.9 million for allegedly causing Medicare to pay for invalid prescription drugs
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Akorn Operating Company LLC, Key Facts
  • Akorn Operating Company LLC, Key Employees
  • Akorn Operating Company LLC, Key Employee Biographies
  • Akorn Operating Company LLC, Major Products and Services
  • Akorn Operating Company LLC, History
  • Akorn Operating Company LLC, Subsidiaries
  • Akorn Operating Company LLC, Joint Venture
  • Akorn Operating Company LLC, Key Competitors
  • Akorn Operating Company LLC, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Akorn Operating Company LLC, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Akorn Operating Company LLC, Recent Deals Summary
List of Figures
  • Akorn Operating Company LLC, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Akorn Operating Company LLC, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Perrigo Co Plc
  • Teva Pharmaceuticals Ltd
  • Bausch Health Companies Inc
  • Allergan Ltd
  • Par Pharmaceutical Inc
  • Hikma Pharmaceuticals Plc
  • Novartis International AG
  • Apotex Inc